GB201001950D0 - Infection prognostic assay - Google Patents

Infection prognostic assay

Info

Publication number
GB201001950D0
GB201001950D0 GBGB1001950.3A GB201001950A GB201001950D0 GB 201001950 D0 GB201001950 D0 GB 201001950D0 GB 201001950 A GB201001950 A GB 201001950A GB 201001950 D0 GB201001950 D0 GB 201001950D0
Authority
GB
United Kingdom
Prior art keywords
cancer
subject
infection
prognostic assay
flc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1001950.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Binding Site Group Ltd
Original Assignee
Binding Site Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Binding Site Group Ltd filed Critical Binding Site Group Ltd
Priority to GBGB1001950.3A priority Critical patent/GB201001950D0/en
Publication of GB201001950D0 publication Critical patent/GB201001950D0/en
Priority to JP2012551687A priority patent/JP5818817B2/ja
Priority to PCT/GB2011/050197 priority patent/WO2011095820A1/en
Priority to CN201180008422.8A priority patent/CN102859362B/zh
Priority to CN201180008402.0A priority patent/CN102859361B/zh
Priority to US13/576,099 priority patent/US20130217030A1/en
Priority to JP2012551689A priority patent/JP5818818B2/ja
Priority to US13/576,063 priority patent/US20130149792A1/en
Priority to EP11702698.9A priority patent/EP2531857B1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB1001950.3A 2010-02-05 2010-02-05 Infection prognostic assay Ceased GB201001950D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB1001950.3A GB201001950D0 (en) 2010-02-05 2010-02-05 Infection prognostic assay
JP2012551687A JP5818817B2 (ja) 2010-02-05 2011-02-04 がん予後診断アッセイ
PCT/GB2011/050197 WO2011095820A1 (en) 2010-02-05 2011-02-04 Infection prognostic assay
CN201180008422.8A CN102859362B (zh) 2010-02-05 2011-02-04 感染预后分析
CN201180008402.0A CN102859361B (zh) 2010-02-05 2011-02-04 癌症预后分析
US13/576,099 US20130217030A1 (en) 2010-02-05 2011-02-04 Infection prognostic assay
JP2012551689A JP5818818B2 (ja) 2010-02-05 2011-02-04 感染症予後診断アッセイ
US13/576,063 US20130149792A1 (en) 2010-02-05 2011-02-04 Cancer prognosis assay
EP11702698.9A EP2531857B1 (en) 2010-02-05 2011-02-04 Infection prognostic assay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1001950.3A GB201001950D0 (en) 2010-02-05 2010-02-05 Infection prognostic assay

Publications (1)

Publication Number Publication Date
GB201001950D0 true GB201001950D0 (en) 2010-03-24

Family

ID=42082582

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1001950.3A Ceased GB201001950D0 (en) 2010-02-05 2010-02-05 Infection prognostic assay

Country Status (6)

Country Link
US (2) US20130149792A1 (enExample)
EP (1) EP2531857B1 (enExample)
JP (2) JP5818817B2 (enExample)
CN (2) CN102859362B (enExample)
GB (1) GB201001950D0 (enExample)
WO (1) WO2011095820A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2519564A (en) * 2013-10-24 2015-04-29 Shared Band Ltd Multicast transmission over bonded broadband
US20170252364A1 (en) 2014-07-30 2017-09-07 Mor Research Applications Ltd. Compositions for treatment of acute lymphoblastic leukemia and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792529A (en) * 1985-10-18 1988-12-20 University Of Rochester Immunoassay of free kappa light chains for the detection of multiple sclerosis
IT1216698B (it) * 1988-04-01 1990-03-08 New Scient Co Spa Metodo per la determinazione della presenza di catene leggere libere in campioni di urina, complesso di preparati per l'esecuzione del metodo, e relativo reagente.
EP0862584B1 (en) 1995-11-03 2004-12-22 The Binding Site Limited Production of antibodies
US6322788B1 (en) * 1998-08-20 2001-11-27 Stanley Arthur Kim Anti-bacterial antibodies and methods of use
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
WO2005116651A2 (en) * 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein
AU2005304320A1 (en) * 2004-11-12 2006-05-18 Board Of Regents, The University Of Texas System Methods of treating hematological malignancies with nucleoside analog drugs
GB0501741D0 (en) * 2005-01-27 2005-03-02 Binding Site The Ltd Antibody
WO2006109793A1 (ja) * 2005-04-12 2006-10-19 Akira Matsumori 心疾患診断用バイオマーカー及びその利用
JP2007292661A (ja) * 2006-04-26 2007-11-08 Akira Matsumori 活動性心筋炎の検出方法および検出試薬
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain

Also Published As

Publication number Publication date
CN102859361A (zh) 2013-01-02
US20130149792A1 (en) 2013-06-13
EP2531857A1 (en) 2012-12-12
JP5818817B2 (ja) 2015-11-18
JP2013519082A (ja) 2013-05-23
CN102859361B (zh) 2015-06-17
JP2013519083A (ja) 2013-05-23
EP2531857B1 (en) 2017-01-18
CN102859362A (zh) 2013-01-02
JP5818818B2 (ja) 2015-11-18
CN102859362B (zh) 2015-11-25
US20130217030A1 (en) 2013-08-22
WO2011095820A1 (en) 2011-08-11

Similar Documents

Publication Publication Date Title
TN2013000358A1 (en) Fgfr and ligands thereof as biomarkers for breast cancer in hr positive subjects
IN2013CN01129A (enExample)
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
BR112013006683A2 (pt) diagnóstico de câncer de mama
WO2012021887A3 (en) Biomarkers for the early detection of breast cancer
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
ES2570380T3 (es) Método para determinar la aptitud de inhibidores de EZH2 humano en tratamiento
EA201390762A1 (ru) Новые биомаркеры для предсказания исхода противораковой иммунотерапии
MY159553A (en) Detection and treatment of pancreatic, ovarian and other cancers
EA201400117A1 (ru) Способы и нуклеиновые кислоты для определения прогноза у больных раком
MX357550B (es) Microarn plasmaticos para la deteccion de cancer colorrectal temprano.
TN2013000464A1 (en) Biomarkers for hedgehog inhibitor therapy
WO2011021041A3 (en) Survival prognostic assay
EP4495266A3 (en) Esophageal cancer detection kit or device, and detection method
BR112016027475A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático
MX358541B (es) Metodos para predecir el riesgo de desarrollar hipertension.
EA201370063A1 (ru) Фосфолипидом рака
AR105618A1 (es) Metilación del promotor del ligando al receptor de muerte programada (pd-l1) en cáncer
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
EP2558597A4 (en) EARLY DETECTION AND STADIFICATION OF COLORECTAL CANCER USING A MICRO-RNA PANEL
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CO6311041A2 (es) Un metodo para determinar y monitorear un cancer ginecologico que comprende la determinacion de niveles de biomarcadores en una muestra biologica
HK1209673A1 (en) Using modulators of ccr5 for treating cancer
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)